BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29110622)

  • 1. Recent Development of Sulfonyl or Sulfonamide Hybrids as Potential Anticancer Agents: A Key Review.
    Rakesh KP; Wang SM; Leng J; Ravindar L; Asiri AM; Marwani HM; Qin HL
    Anticancer Agents Med Chem; 2018; 18(4):488-505. PubMed ID: 29110622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs.
    Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL
    Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and identification of heteroaromatic N-benzyl sulfonamides as potential anticancer agents.
    Hopkins MD; Abebe FA; Scott KA; Ozmer GL; Sheir AA; Schroeder LJ; Sheaff RJ; Lamar AA
    Org Biomol Chem; 2019 Sep; 17(36):8391-8402. PubMed ID: 31469373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM; Ragab FA; Heiba HI; El-Gazzar MG; Zahran SS
    Eur J Med Chem; 2015 Mar; 92():682-92. PubMed ID: 25618015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
    Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
    Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
    Liu Y; Wu Y; Sun L; Gu Y; Hu L
    Eur J Med Chem; 2020 Apr; 191():112181. PubMed ID: 32113125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin-derived hybrids and their anticancer activity.
    Gao F; Sun Z; Kong F; Xiao J
    Eur J Med Chem; 2020 Feb; 188():112044. PubMed ID: 31945642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticancer therapeutic potential of pyrimidine-sulfonamide hybrids.
    Zhang P; Shi C; Dong T; Song J; Du G
    Future Med Chem; 2024; 16(9):905-924. PubMed ID: 38624011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in isatin hybrids as potential anticancer agents.
    Ding Z; Zhou M; Zeng C
    Arch Pharm (Weinheim); 2020 Mar; 353(3):e1900367. PubMed ID: 31960987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline-sulfonamides as potential antitumor agents: synthesis and biological testing.
    Alafeefy AM; Alqasoumi SI; Ashour AE; Alshebly MM
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):375-83. PubMed ID: 22468752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coumarin-containing hybrids and their anticancer activities.
    Zhang L; Xu Z
    Eur J Med Chem; 2019 Nov; 181():111587. PubMed ID: 31404864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isatin-azole hybrids and their anticancer activities.
    Hou Y; Shang C; Wang H; Yun J
    Arch Pharm (Weinheim); 2020 Jan; 353(1):e1900272. PubMed ID: 31691360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.
    Abdel-Aziz AA; El-Azab AS; El-Subbagh HI; Al-Obaid AM; Alanazi AM; Al-Omar MA
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2008-14. PubMed ID: 22318157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation.
    Wan Y; Fang G; Chen H; Deng X; Tang Z
    Eur J Med Chem; 2021 Dec; 226():113837. PubMed ID: 34530384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
    Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrazole hybrids with potential anticancer activity.
    Zhang J; Wang S; Ba Y; Xu Z
    Eur J Med Chem; 2019 Sep; 178():341-351. PubMed ID: 31200236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.